These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10504392)

  • 1. Rational design, conformational studies and bioactivity of highly potent conformationally constrained calcitonin analogues.
    Kapurniotu A; Kayed R; Taylor JW; Voelter W
    Eur J Biochem; 1999 Oct; 265(2):606-18. PubMed ID: 10504392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformationally constrained human calcitonin (hCt) analogues reveal a critical role of sequence 17-21 for the oligomerization state and bioactivity of hCt.
    Kazantzis A; Waldner M; Taylor JW; Kapurniotu A
    Eur J Biochem; 2002 Feb; 269(3):780-91. PubMed ID: 11846779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and conformational requirements for human calcitonin activity: design, synthesis, and study of lactam-bridged analogues.
    Kapurniotu A; Taylor JW
    J Med Chem; 1995 Mar; 38(5):836-47. PubMed ID: 7877149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Side-chain lactam-bridge conformational constraints differentiate the activities of salmon and human calcitonins and reveal a new design concept for potent calcitonin analogues.
    Taylor JW; Jin QK; Sbacchi M; Wang L; Belfiore P; Garnier M; Kazantzis A; Kapurniotu A; Zaratin PF; Scheideler MA
    J Med Chem; 2002 Feb; 45(5):1108-21. PubMed ID: 11855991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations between biological activities and conformational properties for human, salmon, eel, porcine calcitonins and Elcatonin elucidated by CD spectroscopy.
    Siligardi G; Samorí B; Melandri S; Visconti M; Drake AF
    Eur J Biochem; 1994 May; 221(3):1117-25. PubMed ID: 8181470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of conformationally constrained calcitonin (Ct) analogs to the understanding of the structural and conformational requirements of calcitonin bioactivity and to the design of potent agonists.
    Kapurniotu A
    Curr Med Chem; 2004 Nov; 11(21):2845-65. PubMed ID: 15544479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analogues of human calcitonin. IV. Influence of leucine substitutions in positions 12, 16 and 19 on hypocalcaemic activity in the rat.
    Maier R; Kamber B; Riniker B; Rittel W
    Clin Endocrinol (Oxf); 1976; 5 Suppl():327S-332S. PubMed ID: 1052782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the fibrillation of highly amyloidogenic human calcitonin by cucurbit[7]uril with improved bioactivity.
    Shang H; Zhou A; Jiang J; Liu Y; Xie J; Li S; Chen Y; Zhu X; Tan H; Li J
    Acta Biomater; 2018 Sep; 78():178-188. PubMed ID: 30076991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Insights into the Effects of F16L and F19L Substitutions on the Conformation and Aggregation Dynamics of Human Calcitonin.
    Huang F; Huang J; Yan J; Liu Y; Lian J; Sun Q; Ding F; Sun Y
    J Chem Inf Model; 2024 Jun; 64(11):4500-4510. PubMed ID: 38745385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent structural requirements exist for calcitonin receptor binding specificity and adenylate cyclase activation.
    Houssami S; Findlay DM; Brady CL; Martin TJ; Epand RM; Moore EE; Murayama E; Tamura T; Orlowski RC; Sexton PM
    Mol Pharmacol; 1995 Apr; 47(4):798-809. PubMed ID: 7723741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heme prevents highly amyloidogenic human calcitonin (hCT) aggregation: A potential new strategy for the clinical reuse of hCT.
    Ye H; Zhou J; Li H; Gao Z
    J Inorg Biochem; 2019 Jul; 196():110686. PubMed ID: 31003065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibiting Human Calcitonin Fibril Formation with Its Most Relevant Aggregation-Resistant Analog.
    Chen YT; Hu KW; Huang BJ; Lai CH; Tu LH
    J Phys Chem B; 2019 Dec; 123(48):10171-10180. PubMed ID: 31692350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of human and salmon calcitonin secondary structure in solutions with low dielectric constants.
    Arvinte T; Drake AF
    J Biol Chem; 1993 Mar; 268(9):6408-14. PubMed ID: 8454613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlling the self-assembly of human calcitonin: a theoretical approach using molecular dynamics simulations.
    Paul S; Paul S
    Phys Chem Chem Phys; 2021 Jul; 23(26):14496-14510. PubMed ID: 34184696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Y12 nitration of human calcitonin (hCT): A promising strategy to produce non-aggregation bioactive hCT.
    Ye H; Li H; Gao Z
    Nitric Oxide; 2020 Nov; 104-105():11-19. PubMed ID: 32827754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational analysis of elcatonin in solution.
    Ogawa K; Nishimura S; Doi M; Kyogoku Y; Hayashi M; Kobayashi Y
    Eur J Biochem; 1994 Jun; 222(2):659-66. PubMed ID: 8020504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologically potent analogues of salmon calcitonin which do not contain an N-terminal disulfide-bridged ring structure.
    Orlowski RC; Epand RM; Stafford AR
    Eur J Biochem; 1987 Jan; 162(2):399-402. PubMed ID: 3803393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constrained corticotropin-releasing factor (CRF) agonists and antagonists with i-(i+3) Glu-Xaa-DXbb-Lys bridges.
    Koerber SC; Gulyas J; Lahrichi SL; Corrigan A; Craig AG; Rivier C; Vale W; Rivier J
    J Med Chem; 1998 Dec; 41(25):5002-11. PubMed ID: 9836618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Perturbation of Monomers Determines the Amyloid Aggregation Propensity of Calcitonin Variants.
    Liu Y; Wang Y; Zhang Y; Zou Y; Wei G; Ding F; Sun Y
    J Chem Inf Model; 2023 Jan; 63(1):308-320. PubMed ID: 36456917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion sequences of salmon calcitonin that retain the essential biological and conformational features of the intact molecule.
    Epand RM; Epand RF; Stafford AR; Orlowski RC
    J Med Chem; 1988 Aug; 31(8):1595-8. PubMed ID: 3397998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.